Similar biotherapeutic products in Latin America. Regulation and opportunities for patients with autoimmune diseases
Biotherapeutic products have revolutionized medicine, changing the way we can treat some chronic diseases, such as autoimmune diseases. The patent expiry and the high costs of reference biotherapeutic products, among other factors, have promoted interest in similar biotherapeutic products (SBPs), al...
Autores Principales: | , , , |
---|---|
Formato: | Artículo (Article) |
Lenguaje: | Inglés (English) |
Publicado: |
Dovepress open access to scientific and medical research
2013
|
Materias: | |
Acceso en línea: | https://repository.urosario.edu.co/handle/10336/26401 https://doi.org/10.2147/bs.s38572 |